Filing Details
- Accession Number:
- 0001209191-18-053871
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-03 16:48:36
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-03 16:48:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1598646 | Minerva Neurosciences Inc. | NERV | Pharmaceutical Preparations (2834) | 260784194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610499 | H. Joseph Reilly | C/O Minerva Neurosciences, Inc. 1601 Trapelo Road, Suite 286 Waltham MA 02451 | Svp & Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-01 | 15,000 | $4.71 | 29,177 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-10-01 | 10,000 | $5.19 | 39,177 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-01 | 23,300 | $12.02 | 15,877 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-10-01 | 1,700 | $12.62 | 14,177 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-01 | 15,000 | $0.00 | 15,000 | $4.71 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-01 | 10,000 | $0.00 | 10,000 | $5.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,400 | 2025-12-03 | No | 4 | M | Direct | |
| 47,524 | 2025-04-13 | No | 4 | M | Direct |
Footnotes
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.60 to $12.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.60 to $12.69, inclusive.
- This option vested 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.
- This option vested 25% on April 14, 2016 and then in quarterly installments over 3 years thereafter.
Billionaire Hedge Funds
